Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.

Area of Science:

• Biochemistry
• Virology
• Drug Discovery

Background:

• HIV-1 reverse transcriptase (RT) is a crucial enzyme for viral replication.
• Its catalytic activity relies on a heterodimeric structure (p51/p66 subunits).
• Targeting the interaction between these subunits offers a potential therapeutic strategy.

Purpose of the Study:

• To identify novel inhibitors that disrupt the dimerization of HIV-1 RT subunits.
• To improve upon the efficacy of previously identified small molecule MAS0.

Main Methods:

• Rational selection of MAS0 analogues using molecular docking studies.
• In vitro evaluation of selected analogues for their ability to disrupt RT dimer assembly.
• Assessment of inhibitory activity against polymerase and ribonuclease H functions.

Main Results:

• Two novel MAS0 analogues demonstrated enhanced activity in disrupting RT dimerization compared to MAS0.
• These inhibitors effectively reduced the association between p51 and p66 subunits.
• The identified compounds show potential for inhibiting both polymerase and RNase H activities.

Conclusions:

• This study provides a basis for the rational design of more potent HIV-1 RT dimerization inhibitors.
• Disrupting RT subunit association is a viable strategy for developing new anti-HIV therapeutics.
• Further development of these analogues could lead to effective treatments against HIV-1.